AXIN1 and cancer: Therefore, it seems that highly-differentiated cells have an intrinsic mechanism to target Axin1 and activate β-catenin/TCF signaling pathway [31], which is still maintained when the overall level of 5-HT1DR is elevated in cancer cells.